Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TYMP | P19971 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1828273 | 1.00 | TYMP (0.31) | TYMPTDP1ALDH1A1CYP3A4 | |
| SCHEMBL122933 | 0.82 | — | — | |
| SCHEMBL11693170 | 0.78 | — | — | |
| SCHEMBL5567656 | 0.75 | — | — | |
| SCHEMBL2105114 | 0.72 | TYMP (0.41) | TYMPTDP1ALDH1A1CYP3A4 | |
| SCHEMBL18244171 | 0.72 | TYMP (0.41) | TYMPTDP1ALDH1A1CYP3A4 | |
| SCHEMBL3502363 | 0.72 | TYMP (0.41) | TYMPTDP1ALDH1A1CYP3A4 | |
| SCHEMBL21057468 | 0.72 | TYMP (0.41) | TYMPTDP1ALDH1A1CYP3A4 | |
| SCHEMBL3233362 | 0.72 | TYMP (0.41) | TYMPTDP1ALDH1A1CYP3A4 | |
| SCHEMBL18244172 | 0.72 | TYMP (0.41) | TYMPTDP1ALDH1A1CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 38 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3294747-B1 | RUTHENIUM COMPLEXES, METHOD OF PRODUCING THEM, AND THEIR USE | UNIV WARSZAWSKI (PL) | 2021-02-24 | — | — | EP | disclosed |
| EP-3548501-B1 | NOVEL RUTHENIUM COMPLEX, METHOD OF ITS PRODUCTION AND ITS USE IN REACTION OF OLEFINE METATHESIS | UNIV WARSZAWSKI (PL) | 2021-02-17 | — | — | EP | disclosed |
| EP-3564240-A1 | PIPERIDINE INTERMEDIATES | Purdue Pharma L.P. (US) | 2019-11-06 | — | — | EP | disclosed |
| EP-3548501-A1 | NOVEL RUTHENIUM COMPLEX, METHOD OF ITS PRODUCTION AND ITS USE IN REACTION OF OLEFINE METATHESIS | Uniwersytet Warszawski (PL) | 2019-10-09 | — | — | EP | disclosed |
| WO-2018100515-A1 | NOVEL RUTHENIUM COMPLEX, METHOD OF ITS PRODUCTION AND ITS USE IN REACTION OF OLEFINE METATHESIS | UNIWERSYTET WARSZAWSKI (PL) | 2018-06-07 | — | — | WO | disclosed |
| EP-3294747-A1 | RUTHENIUM COMPLEXES, METHOD OF PRODUCING THEM, AND THEIR USE | Uniwersytet Warszawski (PL) | 2018-03-21 | — | — | EP | disclosed |
| EP-3153161-A1 | SMALL MOLECULE INHIBITORS OF TRPA1 | B.R.A.I.N. Biotechnology Research And Information Network AG (DE) | 2017-04-12 | — | — | EP | disclosed |
| US-9585865-B2 | Small molecule modulators of the cold and menthol receptor TRPM8 | B.R.A.I.N. BIOTECHNOLOGY RESEARCH AND INFORMATION NETWORK AG (DE) | 2017-03-07 | — | — | US | disclosed |
| EP-2706995-B1 | SMALL MOLECULE INHIBITORS OF TRPA1 | BRAIN BIOTECHNOLOGY RES & INFORMATION NETWORK AG (DE) | 2016-11-30 | — | — | EP | disclosed |
| EP-2654751-B1 | PHOSPHORUS-SUBSTITUTED QUINOXALINE-TYPE PIPERIDINE COMPOUNDS AND USES THEREOF | PURDUE PHARMA LP (US) | 2016-11-23 | — | — | EP | disclosed |
| WO-2012120099-A2 | SMALL MOLECULE MODULATORS OF THE COLD AND MENTHOL RECEPTOR TRPM8 | B.R.A.I.N. BIOTECHNOLOGY RESEARCH AND INFORMATION NETWORK AG (DE) | 2012-09-13 | — | — | WO | disclosed |
| EP-2497458-A1 | Small molecule modulators of the cold and menthol receptor TRPM8 | B.R.A.I.N. Biotechnology Research And Information Network AG (DE) | 2012-09-12 | — | — | EP | disclosed |
| WO-2012085648-A1 | PHOSPHORUS-SUBSTITUTED QUINOXALINE-TYPE PIPERIDINE COMPOUNDS AND USES THEREOF | PURDUE PHARMA L.P. (US) | 2012-06-28 | — | — | WO | disclosed |
| EP-2433937-A1 | Substituted-quinoxaline-type-piperidine compounds and the uses thereof | Purdue Pharma LP (US) | 2012-03-28 | — | — | EP | disclosed |
| EP-2433935-A1 | Substituted-quinoxaline-type-piperidine compounds and the uses thereof | Purdue Pharma LP (US) | 2012-03-28 | — | — | EP | disclosed |
| EP-2433936-A1 | Substituted-quinoxaline-type-piperidine compounds and the uses thereof | Purdue Pharma LP (US) | 2012-03-28 | — | — | EP | disclosed |
| EP-2120922-A2 | COMPOSITIONS COMPRISING LAMIRIDOSIN, IRIDOIDS OR DERIVATIVES THEREOF FOR TREATMENT OF HEPATITIS C OR HEPATITIS B | NY Financial (International) Corporation (VG) | 2009-11-25 | — | — | EP | disclosed |
| EP-2086958-A2 | SUBSTITUTED-QUINOXALINE-TYPE-PIPERIDINE COMPOUNDS AND THE USES THEREOF | Purdue Pharma LP (US) | 2009-08-12 | — | — | EP | disclosed |
| WO-2009027820-A2 | SUBSTITUTED-QUINOXALINE-TYPE-PIPERIDINE COMPOUNDS AND THE USES THEREOF | PURDUE PHARMA L.P. (DE) | 2009-03-05 | — | — | WO | disclosed |
| WO-2008100547-A2 | COMPOSITIONS COMPRISING LAMIRIDOSIN, IRIDOIDS OR DERIVATIVES THEREOF FOR TREATMENT OF HEPATITIS C OR HEPATITIS B | NY FINANCIAL (INTERNATIONAL) CORPORATION (VG) | 2008-08-21 | — | — | WO | disclosed |